Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • P28 Drug-induced lupus: clinic...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
P28 Drug-induced lupus: clinical and serological features in a tertiary hospital

P28 Drug-induced lupus: clinical and serological features in a tertiary hospital

Bibliographic Details
Main Authors: José Ivorra Cortés, Samuel Leal, Iago Alcántara Álvarez, Inmaculada Chalmeta Verdejo, Hikmat Charia, Marta de la Rubia Navarro, Luis González Puig, Elena Grau García, Anderson Víctor Huaylla Quispe, Isabel Martínez Cordellat, Laura Mas Sánchez, Pablo Francisco Muñoz Martínez, Rosa Negueroles Albuixech, José Eloy Oller Rodríguez, Daniel Ramos Castro, Carmen Riesco Bárcena, Alba Torrat Novés, Ernesto Tovar Sugrañes, Elvira Vicens Bernabeu, Belén Villanueva Mañes, Inés Cánovas Olmos, Carmen Nájera Herranz, José Andrés Román Ivorra
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:Lupus Science and Medicine
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • P9 Increase of IL10 and INFA2 are associated to clinical activity in systemic lupus erythematous patients
    by: José Ivorra Cortés, et al.
    Published: (2024-03-01)
  • P149 Clinical worsening in non-adherent belimumab treatment in SLE
    by: José Ivorra Cortés, et al.
    Published: (2024-03-01)
  • PO.3.61 Renal involvement and cardiovascular risk in systemic lupus erythematosus patients
    by: JA Roman Ivorra, et al.
    Published: (2022-10-01)
  • PO.5.116 Lupus nephritis response in terms of kidney function, urine sediment and serological activity after belimumab treatment
    by: JA Roman Ivorra, et al.
    Published: (2022-10-01)
  • PO.8.175 Antimalarial drugs and electrocardiographic alterations in patients with systemic lupus erythematosus
    by: JA Roman Ivorra, et al.
    Published: (2022-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs